Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08NPG
|
||||
Former ID |
DIB000986
|
||||
Drug Name |
MBX-2044
|
||||
Synonyms |
MBX-102 analogs, Metabolex
|
||||
Indication | Type 2 diabetes [ICD9: 250; ICD10:E11] | Phase 2 | [530092] | ||
Company |
Metabolex Inc
|
||||
Target and Pathway | |||||
Target(s) | Peroxisome proliferator activated receptor gamma | Target Info | Agonist | [530092] | |
PANTHER Pathway | CCKR signaling map ST | ||||
WikiPathways | Wnt Signaling Pathway Netpath | ||||
Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
Differentiation of white and brown adipocyte | |||||
Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | |||||
Transcriptional Regulation of White Adipocyte Differentiation | |||||
Adipogenesis | |||||
SREBP signalling | |||||
Nuclear Receptors | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.